TY  - CHAP
AU  - Wajdi Ben Hania
AU  - Nathalie Ballet
AU  - Pascal Vandeckerkove
AU  - Bernard
Ollivier
AU  - Paul W. O’Toole
AU  - Jean-François Brugère
ED  - Haitham Sghaier
ED  - Afef Najjari
ED  - Kais Ghedira
Y1  - 2017-10-11
PY  - 2017
T1  - Archaebiotics: Archaea as Pharmabiotics for Treating Chronic Disease in Humans?
N2  - Besides the Introductory Chapter that gives a brief overview of archaeal applications, the present book contains four chapters. The first chapter, by Castro-Fernandez et al., provides an interesting depiction of the phylum Euryarchaeota and its biotechnological applications. The second chapter, by Ben Hania and coauthors, focuses on the promotion of the idea that some specific Archaea are potential next-generation probiotics. The third chapter, by Torregrosa-Crespo et al., emphasizes the main characteristics of biocompounds from haloarchaea and their potential uses in biomedicine, pharmacy, and industry. The concluding chapter, by Mizuno et al., proposes a plasmid curing approach for improving the potential of thermophiles in various biotechnological applications and opens new perspectives on industrial valorization.
BT  - Archaea
SP  - Ch. 3
UR  - https://doi.org/10.5772/intechopen.69945
DO  - 10.5772/intechopen.69945
SN  - 978-953-51-3570-8
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-19
ER  -